PNC Financial Services Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
PGA
CCA
PNC Financial Services Group's IDNA Position: Q1 2026 in Review
PNC Financial Services Group increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 450% in Q1 2026, buying an estimated $13.1K and bringing the position to 550 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #3782.
PNC Financial Services Group first reported a position in IDNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $62K in Q3 2021. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.
- PNC Financial Services Group held 550 shares of iShares Genomics Immunology and Healthcare ETF worth $16K as of Q1 2026.
- PNC Financial Services Group bought 450 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $13.1K.
- iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3782 holding.
- PNC Financial Services Group first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2021 and has held it in 21 quarters since.
- PNC Financial Services Group's iShares Genomics Immunology and Healthcare ETF position peaked at $62K in Q3 2021.
- 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.